5,131,275 Shares in Ambev S.A. $ABEV Purchased by DJE Kapital AG

DJE Kapital AG acquired a new stake in shares of Ambev S.A. (NYSE:ABEVFree Report) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 5,131,275 shares of the company’s stock, valued at approximately $14,778,000.

Several other large investors also recently modified their holdings of the stock. Parallel Advisors LLC boosted its stake in Ambev by 20.6% in the 1st quarter. Parallel Advisors LLC now owns 56,786 shares of the company’s stock valued at $166,000 after buying an additional 9,704 shares in the last quarter. Assetmark Inc. raised its stake in Ambev by 61.5% during the first quarter. Assetmark Inc. now owns 872,694 shares of the company’s stock worth $2,548,000 after acquiring an additional 332,425 shares in the last quarter. Angeles Wealth Management LLC bought a new position in shares of Ambev during the first quarter valued at $40,000. Bessemer Group Inc. lifted its holdings in shares of Ambev by 30.4% during the first quarter. Bessemer Group Inc. now owns 30,240 shares of the company’s stock valued at $88,000 after acquiring an additional 7,043 shares during the period. Finally, Bank of New York Mellon Corp boosted its stake in shares of Ambev by 5.4% in the 1st quarter. Bank of New York Mellon Corp now owns 771,710 shares of the company’s stock valued at $2,253,000 after purchasing an additional 39,596 shares in the last quarter. 8.13% of the stock is currently owned by institutional investors.

Ambev Stock Performance

Ambev stock opened at $3.08 on Tuesday. The company has a market cap of $48.62 billion, a PE ratio of 16.24, a PEG ratio of 1.77 and a beta of 0.64. The company has a current ratio of 1.03, a quick ratio of 0.78 and a debt-to-equity ratio of 0.02. Ambev S.A. has a 1 year low of $2.10 and a 1 year high of $3.45. The company’s 50-day moving average is $3.15 and its two-hundred day moving average is $3.00.

Ambev (NYSE:ABEVGet Free Report) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.05 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.05. Ambev had a net margin of 17.69% and a return on equity of 16.63%. The business had revenue of $4.32 billion during the quarter, compared to the consensus estimate of $4.38 billion. Equities analysts anticipate that Ambev S.A. will post 0.2 earnings per share for the current year.

Ambev Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, January 11th. Shareholders of record on Wednesday, June 24th will be issued a dividend of $0.0092 per share. This represents a $0.04 dividend on an annualized basis and a yield of 1.2%. The ex-dividend date of this dividend is Wednesday, June 24th. Ambev’s payout ratio is currently 10.53%.

Insider Activity at Ambev

In other news, insider Paulo Andre Zagman sold 136,250 shares of the stock in a transaction on Tuesday, May 5th. The stock was sold at an average price of $3.41, for a total value of $464,612.50. Following the transaction, the insider owned 230,535 shares of the company’s stock, valued at $786,124.35. This represents a 37.15% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Wall Street Analyst Weigh In

ABEV has been the topic of several analyst reports. Barclays upped their target price on shares of Ambev from $3.00 to $3.50 and gave the stock an “equal weight” rating in a report on Wednesday, May 6th. Weiss Ratings lowered shares of Ambev from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Wednesday, May 6th. Scotiabank cut shares of Ambev from a “sector outperform” rating to a “sector perform” rating in a research note on Wednesday, July 15th. UBS Group raised their price objective on shares of Ambev from $2.65 to $2.90 and gave the stock a “sell” rating in a report on Thursday, May 14th. Finally, Wall Street Zen cut shares of Ambev from a “buy” rating to a “hold” rating in a research note on Monday, July 13th. Six equities research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Ambev has an average rating of “Reduce” and an average price target of $3.09.

Get Our Latest Analysis on Ambev

Ambev Company Profile

(Free Report)

Ambev (NYSE: ABEV) is a Brazilian-based beverage company that produces, distributes and markets a broad portfolio of alcoholic and non-alcoholic drinks. The company’s core business centers on brewing and selling beer, alongside a range of soft drinks, bottled water, energy drinks and other malt-based beverages. Headquartered in São Paulo, Ambev operates an integrated value chain that covers manufacturing, packaging, logistics and commercial sales to retail, on-premise and institutional customers.

The company traces its origins to the 1999 merger of two historic Brazilian breweries, and later became part of the broader global brewing group through subsequent industry consolidations.

Recommended Stories

Want to see what other hedge funds are holding ABEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ambev S.A. (NYSE:ABEVFree Report).

Institutional Ownership by Quarter for Ambev (NYSE:ABEV)

Receive News & Ratings for Ambev Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambev and related companies with MarketBeat.com's FREE daily email newsletter.